Get an alert when SARTORIUS ALBUMEDIX LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-02-09 (in 9mo)

Last made up 2026-01-26

Watchouts

None on the register

Cash

£250K

-0.4% vs 2023

Net assets

£45M

+36.1% vs 2023

Employees

124

+1.6% vs 2023

Profit before tax

£15M

+24.1% vs 2023

Name history

Renamed 6 times since incorporation — the current trading name was adopted 2024-05-28

  1. SARTORIUS ALBUMEDIX LIMITED 2024-05-28 → present
  2. ALBUMEDIX LTD 2016-01-18 → 2024-05-28
  3. NOVOZYMES BIOPHARMA UK LIMITED 2007-09-17 → 2016-01-18
  4. NOVOZYMES DELTA LIMITED 2006-07-14 → 2007-09-17
  5. DELTA BIOTECHNOLOGY LIMITED 1984-09-21 → 2006-07-14
  6. CORAL TOURIST SERVICES LIMITED 1977-12-31 → 1984-09-21
  7. TWINHEATH LIMITED 1973-10-29 → 1977-12-31

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £34,492,000£35,562,000
Operating profit £12,855,000£15,522,000
Profit before tax £12,252,000£15,206,000
Net profit £11,981,000£12,030,000
Cash £251,000£250,000
Total assets less current liabilities £37,288,000£51,289,000
Net assets £33,299,000£45,329,000
Equity £33,299,000£45,329,000
Average employees 122124
Wages £7,531,000£6,943,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 37.3%43.6%
Net margin 34.7%33.8%
Return on capital employed 34.5%30.3%
Current ratio 1.52x5.83x
Interest cover 21.32x48.36x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 44 resigned

Name Role Appointed Born Nationality
DIAMOND, Charlotte Ann Secretary 2019-05-20
FABER, Rene, Dr. Director 2022-09-30 Jul 1975 Slovak
KALINOWSKI, Mark Director 2023-12-18 Nov 1965 British
WOODWARD, Stuart Director 2023-12-18 Jan 1967 British
Show 44 resigned officers
Name Role Appointed Resigned
DAVIES, William Robert Secretary 1996-05-17 1996-10-25
REED, Bryan James Secretary 1991-11-22 1996-05-17
THORPE, Andrew Julian Secretary 1996-10-25 2019-05-20
BOURGART, Joseph Francis Director 1996-05-13 1996-05-17
CAPETOLA, Robert J Director 1994-03-31 1996-05-17
CLUBB, Ian Mcmaster Director 1991-11-22 1994-09-30
CONNELL, William Edward Director 1996-05-17
DE WIT, Hugo Laurens Director 2022-09-30 2024-04-01
DEBETHIZY, Joseph Donald Director 2017-12-28 2022-09-30
DEGN, Pia Botting Director 2015-01-30 2015-12-31
EPSTEIN, Gil Director 1996-05-17 1996-10-22
FUHGE, Peter Director 1996-05-17 2000-10-13
GARLAND, Stephen George Director 1998-03-02 2006-07-06
GRAM, Anders Peter Director 2006-07-06 2007-06-04
ISAAC, Anthony Eric Director 1994-10-17 1996-05-17
JENSEN, Camilla Kinch Director 2015-12-31 2017-12-28
JENSEN, Randi Camilla Kinch Director 2006-07-06 2008-02-08
KIRK, Christopher William Director 1991-11-22 1993-01-11
KORGAARD-MOLLERUP, Soren Director 2011-06-06 2015-01-30
MCGLYNN, Martin M Director 1991-11-22 1994-02-09
MCGLYNN, Martin M Director 1994-02-09
MERKLE, Werner Director 1998-03-02 2006-07-06
MERSER, Kristian Director 2006-07-06 2009-09-01
MOLLER, Jonas Skjodt Director 2018-08-23 2023-12-18
MOORE, Margaret Wallis Director 1996-05-14 1996-05-17
MURA, Henri Director 1996-05-17 1997-01-31
MURPHY, John Marcus Director 1991-11-22 1992-07-31
NIELSEN, Jacob Director 2009-09-01 2011-06-06
PRECHT, Tobias Director 2022-09-30 2023-12-18
ROSHOLM, Peter Director 2017-12-28 2022-09-30
ROSHOLM, Peter Director 2007-06-04 2015-12-31
SAITH, Vijay Kumar Director 1996-05-17
SCHMIDT, Arne Wintherhalter Director 2006-07-06 2007-09-30
SCHULZE, Gail Director 1998-03-02 2003-11-28
SEDOR, John A Director 1996-05-17 1998-01-30
SLEEP, Darrell, Dr Director 2016-01-01 2017-12-21
STEFFENSEN, Uno Bonde Director 2008-02-08 2009-09-01
STOLL, Roger Gerhard, Dr Director 1994-02-09 1996-05-17
STUART, Gloria Jean Director 1994-06-01 1996-05-17
TARALLO, Angelo Nicholas Director 1994-06-01
THOMAS, Paul Director 1994-02-09 1996-05-17
THORPE, Andrew Julian Director 2017-12-28 2022-09-30
THORPE, Andrew Julian Director 1998-03-02 2006-07-06
VILTOFT, Mikkel Director 2009-09-01 2017-12-28

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Sartorius Stedim Biotech S.A. Corporate entity Shares 75–100%, Voting 75–100% 2022-09-30 Active
Mr Peter Rosholm Individual Shares 75–100%, Voting 75–100%, Appoints directors 2017-12-28 Ceased 2022-09-30
Albumedix A/S Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Ceased 2017-12-28

Filing timeline

Last 20 of 252 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2024-05-28 CERTNM Certificate change of name company PDF
Date Type Category Description
2026-01-30 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-09-17 AA accounts Accounts with accounts type full
2025-01-28 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-12 AA accounts Accounts with accounts type full
2024-05-28 CERTNM change-of-name Certificate change of name company PDF
2024-05-13 MR04 mortgage Mortgage satisfy charge full PDF
2024-04-11 TM01 officers Termination director company with name termination date PDF
2024-01-26 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-12-19 AP01 officers Appoint person director company with name date PDF
2023-12-19 AP01 officers Appoint person director company with name date PDF
2023-12-19 TM01 officers Termination director company with name termination date PDF
2023-12-19 TM01 officers Termination director company with name termination date PDF
2023-10-11 AA accounts Accounts with accounts type full
2023-01-26 CS01 confirmation-statement Confirmation statement with updates PDF
2023-01-04 PSC05 persons-with-significant-control Change to a person with significant control PDF
2022-11-03 CH01 officers Change person director company with change date PDF
2022-11-03 TM01 officers Termination director company with name termination date PDF
2022-10-19 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2022-10-19 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2022-10-07 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers

Official Companies House page